FDA — authorised 24 September 1996
- Application: NDA020533
- Marketing authorisation holder: FRESENIUS KABI USA
- Local brand name: NAROPIN
- Indication: SOLUTION — INJECTION
- Status: approved
🇺🇸 Ropivacaine Infusion from ON-Q Pump in United States
FDA authorised Ropivacaine Infusion from ON-Q Pump on 24 September 1996
Marketing authorisations
FDA
- Status: approved
Ropivacaine Infusion from ON-Q Pump in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Ropivacaine Infusion from ON-Q Pump approved in United States?
Yes. FDA authorised it on 24 September 1996; FDA has authorised it.
Who is the marketing authorisation holder for Ropivacaine Infusion from ON-Q Pump in United States?
FRESENIUS KABI USA holds the US marketing authorisation.